Product Information
ANORO ELLIPTA 62.5-25 MCG INH is a brand product labeled by GlaxoSmithKline LLC, priced at $8.0323 per EA under NDC 00173086906. Its NADAC has been published 403 times since Nov 21, 2018.
FDA first approved this application on Dec 18, 2013.
Strength
62.5; 25 ug/1; ug/1
Manufacturer
GlaxoSmithKline LLCNDC
00173086906
Classification
Brand
Dosage Form
POWDER
Route
RESPIRATORY (INHALATION)
Effective Date
8/19/2026
Active Ingredients
UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATEApproval Type
New Drug (NDA)
FDA Application
NDA203975FDA Approved
12/18/2013
On Market Since
1/31/2014
Pharmacological Classes
Price Statistics
The NADAC for ANORO ELLIPTA 62.5-25 MCG INH has been published 403 times since Nov 21, 2018, and over the history we have for it it has risen 22.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $8.0323 per EA |
|---|---|
| All-time high | $8.0539 (Jun 11, 2025) |
| All-time low | $6.5501 (Nov 21, 2018) |
| 52-week high | $8.0452 |
| 52-week low | $8.0316 |
| Median price | $7.3720 |
| Average price | $7.4188 |
| Largest weekly change | +3.0% (Jan 9, 2019) |
| Weeks tracked | 403 |
| Tracking since | Nov 21, 2018 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 38% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ANORO ELLIPTA 62.5-25 MCG INH?
The current National Average Drug Acquisition Cost (NADAC) for ANORO ELLIPTA 62.5-25 MCG INH, manufactured by GlaxoSmithKline LLC, is $8.0323 per EA (NDC 00173086906), effective Aug 19, 2026.
How has the price of ANORO ELLIPTA 62.5-25 MCG INH changed over time?
Over the history we have for it, the NADAC for ANORO ELLIPTA 62.5-25 MCG INH has risen 22.6%. It has been tracked across 403 weekly CMS publications since Nov 21, 2018.
What are the highest and lowest recorded NADAC prices for ANORO ELLIPTA 62.5-25 MCG INH?
Since Nov 21, 2018, the NADAC for ANORO ELLIPTA 62.5-25 MCG INH has ranged from a low of $6.5501 (Nov 21, 2018) to a high of $8.0539 (Jun 11, 2025), with a median of $7.3720 per EA.
Are there cheaper alternatives to ANORO ELLIPTA 62.5-25 MCG INH?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, UMECLIDINIUM-VILANTEROL ELLIPTA 62.5-25 MCG INH, is $4.9512 per EA — about 38% below ANORO ELLIPTA 62.5-25 MCG INH.
Who manufactures ANORO ELLIPTA 62.5-25 MCG INH?
ANORO ELLIPTA 62.5-25 MCG INH (NDC 00173086906) is labeled by GlaxoSmithKline LLC, and CMS classifies it as a brand product.